Estimating the Lifetime Treatment Burden of Patients With Follicular Lymphoma: A Retrospective Study Using Real-World Multicenter Data.

Aino RajamäkiMika HujoReijo Sund Roosa Enni Inkeri PrusilaMilla E L KuusistoHanne KuitunenEsa JantunenSantiago MercadalMarc Sorigue Juan-Manuel Sancho Kaisa SunelaOuti Kuittinen

Published in: JCO clinical cancer informatics (2023)

Despite long remissions, approximately two thirds of the patients receive at least two lines and one-third at least three lines of therapy during their lifetime.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
electronic health record
clinical trial
risk factors
cross sectional
big data
machine learning
replacement therapy
cell therapy